- Home
- AVAH
as 04-18-2025 1:31pm EST
Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). Private Duty Services include private duty nursing (PDN) and pediatric therapy services. Revenue is derived from pediatric healthcare services provided to patients including private duty nursing and therapy services, adult home health and hospice services (collectively patient revenue) and from the delivery of enteral nutrition and other products to patients.
| Founded: | 1984 | Country: | United States |
| Employees: | N/A | City: | ATLANTA |
| Market Cap: | 972.5M | IPO Year: | 2021 |
| Target Price: | $5.00 | AVG Volume (30 days): | 288.0K |
| Analyst Decision: | Hold | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.06 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.11 - $6.19 | Next Earning Date: | 05-08-2025 |
| Revenue: | $2,024,506,000 | Revenue Growth: | 6.82% |
| Revenue Growth (this year): | 6.64% | Revenue Growth (next year): | 5.00% |
Stock Insider Trading Activity of Aveanna Healthcare Holdings Inc. (AVAH)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| J.H. Whitney Equity Partners VII, LLC | AVAH | 10% Owner | Apr 1 '25 | Sell | $5.63 | 18,204 | $102,488.52 | 15,679,913 | |
| WILLIAMS ROBERT M JR | AVAH | 10% Owner | Apr 1 '25 | Sell | $5.63 | 20,324 | $114,424.12 | 31,376,094 | |
| VIGANO PAUL R | AVAH | 10% Owner | Apr 1 '25 | Sell | $5.63 | 20,324 | $114,424.12 | 546,247 | |
| J.H. Whitney Equity Partners VII, LLC | AVAH | 10% Owner | Mar 24 '25 | Sell | $5.63 | 447 | $2,518.40 | 15,679,913 | |
| WILLIAMS ROBERT M JR | AVAH | 10% Owner | Mar 24 '25 | Sell | $5.64 | 500 | $2,817.00 | 31,376,094 | |
| VIGANO PAUL R | AVAH | 10% Owner | Mar 24 '25 | Sell | $5.64 | 500 | $2,817.00 | 546,247 | |
| J.H. Whitney Equity Partners VII, LLC | AVAH | 10% Owner | Mar 18 '25 | Sell | $5.48 | 134,084 | $735,176.84 | 15,679,913 | |
| WILLIAMS ROBERT M JR | AVAH | 10% Owner | Mar 18 '25 | Sell | $5.48 | 150,000 | $822,443.55 | 31,376,094 | |
| VIGANO PAUL R | AVAH | 10% Owner | Mar 18 '25 | Sell | $5.48 | 150,000 | $822,443.55 | 546,247 |
Latest Aveanna Healthcare Holdings Inc. News
AVAH Breaking Stock News: Dive into AVAH Ticker-Specific Updates for Smart Investing
GlobeNewswire
2 days ago
Aveanna Announces First Quarter 2025 Earnings Release Date and Conference Call
MT Newswires
8 days ago
Truist Trims Price Target on Aveanna Healthcare to $5.50 From $6, Maintains Hold Rating
Zacks
8 days ago
Centene Extends SilverSummit's Presence to the Edges of Nevada
Zacks
9 days ago
LifeStance Health (LFST) Surges 5.8%: Is This an Indication of Further Gains?
MT Newswires
16 days ago
Sector Update: Health Care Stocks Lean Lower Premarket Thursday
MT Newswires
16 days ago
Aveanna Healthcare to Acquire Thrive Skilled Pediatric Care
GlobeNewswire
16 days ago
Aveanna Healthcare Holdings Announces Agreement to Acquire Thrive Skilled Pediatric Care
Zacks
19 days ago
Is Arbutus Biopharma (ABUS) Outperforming Other Medical Stocks This Year?
Compare AVAH vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "AVAH Aveanna Healthcare Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.